PER-014-98已完成未知
TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C USING ALFA 2B INTERFERON ASSOCIATED WITH RIBAVIRINE, COMPARING IT WITH THE SAME SCHEME PREVIOUS FROM DAILY ADMINISTRATION FOR 2 WEEKS OF ALFA 2 B INTERFERO
试验速览
- 阶段
- 未知
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C (HCC) USING PEG-INTERFERON ALPHA 2B AND RIBAVIRINEPER-039-01SCHERING PLOUGH RESEARCH INSTITUTE,
已完成
不适用
TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS B (HCB) USING PEG-INTERFERON ALPHA 2BPER-040-01SCHERING PLOUGH RESEARCH INSTITUTE,
尚未招募
2 期
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Evaluate the Safety and Efficacy of GS-9620 for the Treatment of Virally-Suppressed Subjects with Chronic Hepatitis BACTRN12614000628640Gilead Sciences, Inc.150
已完成
2 期
Study of new therapy in patients with chronic hepatitis C including liver cirrhosischronic hepatitis C and liver cirrhosisJPRN-UMIN000008289niversity of Tsukuba10
尚未招募
Unknown
Systemic therapy for Unresectable Hepatocellular Carcinoma: Therapeutic Effectiveness by Treatment Modality and Optimal Drug Use Ordernresectable hepatocellular carcinomaJPRN-UMIN000051797Japanese Red Cross Society Himeji Hospital5,000